rs755065651
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM2PM5PP2PP3_ModeratePP5
The NM_014874.4(MFN2):c.776G>A(p.Arg259His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000124 in 1,614,044 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R259L) has been classified as Likely pathogenic.
Frequency
Consequence
NM_014874.4 missense
Scores
Clinical Significance
Conservation
Publications
- neuropathy, hereditary motor and sensory, type 6AInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- axonal hereditary motor and sensory neuropathyInheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
- Charcot-Marie-Tooth disease type 2A2Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- hereditary motor and sensory neuropathy type 6Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- multiple symmetric lipomatosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- severe early-onset axonal neuropathy due to MFN2 deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152160Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251492 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461884Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727244 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152160Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74340 show subpopulations
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 2A2 Pathogenic:1
Variant summary: MFN2 c.776G>A (p.Arg259His) results in a non-conservative amino acid change in the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function all suggest that this variant is likely to be disruptive. The variant allele was found at a frequency of 4e-06 in 251492 control chromosomes. c.776G>A has been observed in multiple heterozygous individual(s) affected with Charcot-Marie Disease Type 2A2 (example: Schabhuttl_2014, Lin_2020). These data indicate that the variant is likely to be associated with disease. Other variant(s) that disrupt this residue have been observed in individuals with MFN2-related conditions (Variation ID: 155730, 637279). The following publications have been ascertained in the context of this evaluation (PMID: 24627108, 31832804). ClinVar contains an entry for this variant (Variation ID: 577496). Based on the evidence outlined above, the variant was classified as pathogenic. -
Charcot-Marie-Tooth disease type 2 Pathogenic:1
This variant has been observed in several individuals affected with Charcot-Marie-Tooth disease and to segregate with Charcot-Marie-Tooth disease in a family (PMID: 24450158, 24863639, 24627108, 26989944). ClinVar contains an entry for this variant (Variation ID: 577496). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. Variants that disrupt the p.Arg259 amino acid residue in MFN2 have been observed in affected individuals (PMID: 22492563, 24957169, 25802885, 25957633, 19350291). This suggests that it is a clinically significant residue, and that other variants that disrupt this residue are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic. This sequence change replaces arginine with histidine at codon 259 of the MFN2 protein (p.Arg259His). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and histidine. This variant is present in population databases (rs755065651, ExAC 0.001%). -
Charcot-Marie-Tooth disease Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The p.R259H variant (also known as c.776G>A), located in coding exon 6 of the MFN2 gene, results from a G to A substitution at nucleotide position 776. The arginine at codon 259 is replaced by histidine, an amino acid with highly similar properties. This variant has been detected in the heterozygous state in multiple patients with Charcot-Marie-Tooth Type 2A (CMT2A) disease (Schabhüttl M et al. J Neurol, 2014 May;261:970-82; Choi BO et al. Clin Genet, 2015 Jun;87:594-8; Luigetti M et al. Clin Neurol Neurosurg, 2016 May;144:67-71; Wu R et al. Neuropathology, 2018 Oct;38:463-467; Lin S et al. Neurogenetics, 2020 04;21:79-86). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at